Prasol Chemicals Limited (PRASOLCHEM)
Snapshot
Prasol Chemicals Limited closed at ₹772.45 on 4 Nov 2026. Data as of 4 Nov 2026.
Price
- Market Cap
- ₹4,572 Cr
OwnershipSep 2026
- Promoters
- 75.25%
- FIIs
- 0.02%
- DIIs
- 10.19%
Shareholding for the quarter ended September 2026; changes in percentage points.
Exchange activity4 Nov 2026
- Delivery
- 42.21% vs 33.28% average
- Volume vs its average
- 0.2×
- Price band
- 2 band closes in ~20 sessions
Events
- Latest results
- Q2 FY27, filed 2 Nov 2026
- Board meeting filing
- 28 Sep 2026
Exchange data. Each figure as its own page shows it; the dates are the data's. Information only, not investment advice.
📈 Share price & events
Q2 FY27 results
Prasol Chemicals Limited reported Q2 FY27 results on 2 Nov 2026: revenue ₹413 Cr, and net profit ₹38.0 Cr; the operating margin was 14.0%.
| Q2 FY27 (₹ Cr) | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹413 | — | -4.9% |
| Operating profit | ₹57.8 | — | -36.0% |
| Net profit | ₹38.0 | — | -37.8% |
| EPS (₹) | 6.52 | — | -38.0% |
| Operating margin | 14.0% | — | — |
- H1 FY27 operating cash flow was negative despite a profit
Quality of profit: of pre-tax profit of ₹49.9 Cr, ₹49.1 Cr (98%) came from the core business and the rest from other income and one-off items.
Share price since the results: -5.5% (close before the filing to the latest close).
PRASOLCHEM delivery percentage
NSE end-of-day data for
On Wed, 4 Nov 2026, 42.21% of the PRASOLCHEM shares traded on NSE were taken to delivery, against the stock's own 20-session average of 33.28%. The price rose 2.36% on that unusually high delivery, the pattern the delivery dashboard labels accumulation. Volume was 0.2 times its average, well below normal. It closed at a price band (circuit) on 2 sessions in about the last 20.
Delivery in the last 5 sessions: 49.3% · 29.2% · 30.4% · 31.9% · 42.2%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Prasol Chemicals released its Q2 and H1 FY27 earnings presentation, posting a 38.6% YoY rise in Q2 revenue to ₹412.6 crore and a 122.2% jump in PAT to ₹37.9 crore. For H1 FY27, revenue reached ₹846.2 crore (up 37.1% YoY) with an EBITDA of ₹148.0 crore (up 106.6% YoY) and EBITDA margin expanding 590 bps to 17.5%. The company reaffirmed its full-year FY27 guidance of ₹1,550–1,650 crore in revenue and ₹240–250 crore in EBITDA. Margins benefited in Q1 from geopolitical supply chain impacts boosting average selling prices by ₹25 crore, which normalized in Q2.
- Q2 FY27 revenue from operations grew 38.6% YoY to ₹412.6 crore compared to ₹297.6 crore in Q2 FY26.
- Q2 FY27 PAT jumped 122.2% YoY to ₹37.9 crore from ₹17.1 crore, with EBITDA margin rising 460 bps to 14.0%.
- H1 FY27 revenue expanded 37.1% YoY to ₹846.2 crore, and H1 PAT grew 138.9% YoY to ₹99.0 crore.
- FY27 annual guidance maintained at ₹1,550–1,650 crore for revenue and ₹240–250 crore for EBITDA.
- Long-term borrowings reduced to ₹0.0 crore as of September 2026 from ₹47.0 crore in March 2026.
Prasol Chemicals Limited has submitted its statement of deviation or variation for the quarter ended September 30, 2026, pursuant to Regulation 32 of SEBI LODR. The company confirmed that there has been no deviation or variation in the utilization of funds raised through its Initial Public Offering from the objects stated in its September 10, 2026 prospectus. Total funds raised via the IPO amounted to ₹800 million (₹80 crore) with allotment completed on September 11, 2026. The Audit Committee reviewed the report and noted zero deviations or auditor comments.
- Confirmed zero deviation or variation in utilization of IPO proceeds for the quarter ended September 30, 2026
- Total funds raised through the Initial Public Offering stood at 800 Millions (allotment date September 11, 2026)
- Audit Committee and statutory auditors offered Nil comments or objections
- Utilisation is aligned with objects stated in the prospectus dated September 10, 2026
Prasol Chemicals released the transcript of its maiden earnings call post-listing on September 16, 2026. Management guided for an annual turnover of ₹1,550 to ₹1,600 crore, following ₹1,200+ crore turnover and 21%+ ROCE in the prior year. The company utilized ₹60 crore from IPO proceeds to pay off all targeted debt, making it virtually net debt-free. It has surplus land of 20 acres at Mahad and 10-12 acres at Khopoli to support upcoming product expansions as plants near 70%+ capacity utilization.
- Turnover guidance of ₹1,550 to ₹1,600 crore for the year, up from ₹1,200+ crore in FY26
- Repaid ₹60 crore of debt post-IPO to achieve targeted debt-free status
- Surplus expansion land ready: 20 acres at Mahad and 10-12 acres at Khopoli
- Current portfolio includes 150+ specialty chemical products exported to 60+ countries with top 10% clients contributing 24-25% turnover
- Plant utilization expected to cross 70%+ by end of year, triggering planned expansions across products
Prasol Chemicals filed its Q1 FY27 earnings presentation following its recent IPO listing on September 16, 2026. Total revenue grew 35.5% YoY to ₹433.6 crore, while EBITDA surged 122.4% YoY to ₹90.3 crore, and PAT increased 150.7% to ₹61.0 crore. Operating margins were temporarily boosted by higher average selling prices worth ₹25 crore due to geopolitical supply chain disruptions. The company plans a ₹300 crore capex for expanding existing product lines and guides for FY27 revenue of ₹1,550–1,650 crore.
- Q1 FY27 revenue grew 35.5% YoY to ₹433.6 crore versus ₹319.6 crore in Q1 FY26
- EBITDA surged 122.4% YoY to ₹90.3 crore, with margins expanding to 20.8% (aided by a ₹25 crore ASP increase)
- PAT jumped 150.7% YoY to ₹61.0 crore, with EPS rising to ₹10.52 from ₹4.20
- Management provided FY27 guidance of ₹1,550–1,650 crore in revenue and ₹240–250 crore in EBITDA (excluding geopolitical fluctuations)
- Planned capex of ₹300 crore in existing product lines alongside turnaround of the Mahad facility
Prasol Chemicals reported its first financial results post-listing for the quarter ended June 30, 2026, posting a 150.7% YoY increase in Net Profit to ₹610.23 million (₹61.02 crore) compared to ₹243.38 million in Q1 FY25. Revenue from operations increased 35.7% YoY to ₹4,336.46 million (₹433.65 crore) from ₹3,195.60 million. Profit Before Tax climbed 154.9% YoY to ₹835.58 million. The board also noted the retirement of Dr. Chitra Vaidya, Vice-President – R&D, effective September 30, 2026.
- Revenue from operations grew 35.7% YoY to ₹4,336.46 million in Q1 FY27
- Net profit after tax rose 150.7% YoY to ₹610.23 million from ₹243.38 million
- Diluted EPS increased to ₹10.52 for the quarter compared to ₹4.20 in Q1 FY25
- Retirement of Dr. Chitra Vaidya, Vice-President – R&D, effective close of September 30, 2026
- Completed ₹5,000 million IPO and listed on NSE/BSE on September 16, 2026
Prasol Chemicals reported an inadvertent violation of SEBI Prohibition of Insider Trading (PIT) Regulations involving a deemed Designated Person, Mrs. Jamini Ashit Shroff, relative of CFO Rahul Ashit Shroff. On September 18, 2026, 300 shares were purchased for a total value of Rs 1,91,127 during a closed trading window. The company concluded the trade was unintended, lacked illicit profit motive, and issued a warning letter to the Designated Person. No monetary penalties or disgorgements were levied.
- 300 shares traded at an aggregate value of Rs 1,91,127
- Trade executed on September 18, 2026, during the trading window closure period
- Designated Person involved: CFO and Finance Director Rahul Ashit Shroff (via deemed DP Mrs. Jamini Ashit Shroff)
- Company issued a warning letter; no financial penalty imposed as trade was deemed inadvertent
Prasol Chemicals Limited has updated and submitted its list of Key Managerial Personnel authorized to determine the materiality of events or information pursuant to Regulation 30(5) of SEBI LODR Regulations. A total of 7 officials have been authorized, including the Chairman, MD, Joint MD, two Whole-time Directors, the CFO, and the Company Secretary. This is a standard statutory compliance disclosure and has no direct financial or operational impact on the business.
- 7 Key Managerial Personnel authorized under SEBI LODR Regulation 30(5)
- Authorized officials include Chairman Nishith Shah, MD Gaurang Parikh, and Joint MD Dhaval Parikh
- Filing submitted on 16th September, 2026 to both NSE and BSE
Prasol Chemicals Limited has submitted a regulatory intimation under Regulation 6(1) of SEBI LODR Regulations, 2015. The company confirmed that Ms. Kiran Rajendra Agrawal, originally appointed as Company Secretary on February 1, 2022, continues to serve as the Compliance Officer. This filing represents a routine procedural confirmation to the stock exchanges. There is no impact on operations, strategy, or financial standing.
- Intimation submitted pursuant to Regulation 6(1) of SEBI LODR Regulations, 2015
- Confirmation that Ms. Kiran Rajendra Agrawal was appointed as Company Secretary on February 1, 2022
- Ms. Agrawal continues in the role of Compliance Officer of the company
- Filing released to NSE and BSE on September 16, 2026
Prasol Chemicals Limited has informed the exchanges regarding compliance under Regulation 6(1) of SEBI LODR Regulations, 2015. The company confirmed that Ms. Kiran Rajendra Agrawal, who was appointed as Company Secretary on February 1, 2022, continues to serve as the Compliance Officer. This filing is purely administrative in nature to fulfill statutory disclosure records.
- Confirmation of Compliance Officer under Regulation 6(1) of SEBI LODR Regulations, 2015
- Ms. Kiran Rajendra Agrawal appointed as Company Secretary on 1st February 2022 continues in role
- Intimation filed with BSE (544912) and NSE (PRASOLCHEM) on 16th September, 2026
Prasol Chemicals Limited has informed the exchanges regarding the closure of its trading window effective September 16, 2026. The closure applies to all designated persons, their immediate relatives, and insiders under SEBI (Prohibition of Insider Trading) Regulations. The window will remain shut until 48 hours after the declaration of financial results for the quarter ended June 30, 2026. This is a standard statutory compliance filing with no operational or financial impact.
- Trading window closed with effect from 16th September, 2026
- Pertains to financial results for the quarter ended 30th June, 2026
- Trading window re-opens 48 hours after the announcement of the quarterly financial results
Company profile
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
